209 related articles for article (PubMed ID: 18056563)
1. Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis.
Mikaeloff Y; Caridade G; Rossier M; Suissa S; Tardieu M
Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1176-82. PubMed ID: 18056563
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
Mikaeloff Y; Caridade G; Suissa S; Tardieu M
Neurology; 2009 Mar; 72(10):873-80. PubMed ID: 18843097
[TBL] [Abstract][Full Text] [Related]
3. Vaccinations and risk of central nervous system demyelinating diseases in adults.
DeStefano F; Verstraeten T; Jackson LA; Okoro CA; Benson P; Black SB; Shinefield HR; Mullooly JP; Likosky W; Chen RT;
Arch Neurol; 2003 Apr; 60(4):504-9. PubMed ID: 12707063
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination.
Mikaeloff Y; Caridade G; Assi S; Tardieu M; Suissa S;
Brain; 2007 Apr; 130(Pt 4):1105-10. PubMed ID: 17276994
[TBL] [Abstract][Full Text] [Related]
5. Clinically observed chickenpox and the risk of childhood-onset multiple sclerosis.
Mikaeloff Y; Caridade G; Suissa S; Tardieu M;
Am J Epidemiol; 2009 May; 169(10):1260-6. PubMed ID: 19329530
[TBL] [Abstract][Full Text] [Related]
6. Parental smoking at home and the risk of childhood-onset multiple sclerosis in children.
Mikaeloff Y; Caridade G; Tardieu M; Suissa S;
Brain; 2007 Oct; 130(Pt 10):2589-95. PubMed ID: 17827175
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B vaccination and the risk of multiple sclerosis.
Ascherio A; Zhang SM; Hernán MA; Olek MJ; Coplan PM; Brodovicz K; Walker AM
N Engl J Med; 2001 Feb; 344(5):327-32. PubMed ID: 11172163
[TBL] [Abstract][Full Text] [Related]
8. Recent use of oral contraceptives and the risk of multiple sclerosis.
Alonso A; Jick SS; Olek MJ; Ascherio A; Jick H; Hernán MA
Arch Neurol; 2005 Sep; 62(9):1362-5. PubMed ID: 16157743
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile.
Tosti ME; Traversa G; Bianco E; Mele A
Ital J Gastroenterol Hepatol; 1999; 31(5):388-91. PubMed ID: 10470598
[TBL] [Abstract][Full Text] [Related]
10. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
[TBL] [Abstract][Full Text] [Related]
11. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B vaccine and risk of multiple sclerosis.
DeStefano F; Verstraeten T; Chen RT
Expert Rev Vaccines; 2002 Dec; 1(4):461-6. PubMed ID: 12901584
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B vaccination and central demyelination - History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period.
Mouchet J; Bégaud B
Vaccine; 2019 Apr; 37(15):2142-2148. PubMed ID: 30851966
[TBL] [Abstract][Full Text] [Related]
14. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
[TBL] [Abstract][Full Text] [Related]
15. Development of multiple sclerosis after vaccination against hepatitis B: a study based on human leucocyte antigen haplotypes.
Ozakbas S; Idiman E; Yulug B; Pakoz B; Bahar H; Gulay Z
Tissue Antigens; 2006 Sep; 68(3):235-8. PubMed ID: 16948644
[TBL] [Abstract][Full Text] [Related]
16. [The first episode of central nervous system demyelinization and hepatitis B virus vaccination].
Touzé E; Gout O; Verdier-Taillefer MH; Lyon-Caen O; Alpérovitch A
Rev Neurol (Paris); 2000 Mar; 156(3):242-6. PubMed ID: 10740095
[TBL] [Abstract][Full Text] [Related]
17. Vaccinations and multiple sclerosis.
Gout O
Neurol Sci; 2001 Apr; 22(2):151-4. PubMed ID: 11603617
[TBL] [Abstract][Full Text] [Related]
18. [Multiple sclerosis in children: environmental risk factors].
Tardieu M; Mikaeloff Y
Bull Acad Natl Med; 2008 Mar; 192(3):507-9; discussion 509-10. PubMed ID: 18819696
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B vaccination: risk-benefit profile and the role of systematic reviews in the assessment of causality of adverse events following immunisation.
Jefferson T; Traversa G
J Med Virol; 2002 Jul; 67(3):451-3. PubMed ID: 12116044
[TBL] [Abstract][Full Text] [Related]
20. Elimination of acute hepatitis B among adolescents after one decade of an immunization program targeting Grade 6 students.
Patrick DM; Bigham M; Ng H; White R; Tweed A; Skowronski DM
Pediatr Infect Dis J; 2003 Oct; 22(10):874-7. PubMed ID: 14551487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
